Evidence map›Paper›PMID 33524610›Full record

ArticleEuropean journal of medical genetics2021

Genetic counseling for women with 45,X/46,XX mosaicism: Towards more personalized management.

Emma A Snyder, Adrianna K San Roman, Raul E Piña-Aguilar, Marcie A Steeves, Erin A McNamara, Irene Souter, Frances J Hayes, Lynne L Levitsky, Angela E Lin

Open access · greenAbstract read
In one paragraph

Article in European journal of medical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Emma A SnyderMassGeneral Hospital for Children, Medical Genetics, Department of Pediatrics, Boston, MA, USA.
Adrianna K San RomanWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Raul E Piña-AguilarBrigham and Women's Hospital, Obstetrics and Gynecology, Boston, MA, USA.
Marcie A SteevesMassGeneral Hospital for Children, Medical Genetics, Department of Pediatrics, Boston, MA, USA.
Erin A McNamaraMassGeneral Hospital for Children, Medical Genetics, Department of Pediatrics, Boston, MA, USA.
Irene SouterMassachusetts General Hospital, Reproductive Endocrinology and Infertility, Boston, MA, USA.
Frances J HayesMassachusetts General Hospital, Reproductive Endocrine Unit, Boston, MA, USA.
Lynne L LevitskyMassGeneral Hospital for Children, Pediatric Endocrinology, Boston, MA, USA.
Angela E LinMassGeneral Hospital for Children, Medical Genetics, Department of Pediatrics, Boston, MA, USA. Electronic address: lin.angela@mgh.harvard.edu.
Massachusetts General Hospital · USBrigham and Women's Hospital · USWhitehead Institute for Biomedical Research · US

Funding

Effects of sex chromosome constitution on global gene expressionF32HD091966 · NICHD · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI SAN ROMAN, ADRIANNA K · 2017 to 2020
$224k
NICHD NIH HHS F32 HD091966
6 · The paper itself

Abstract

Despite numerous clinical series, consistent karyotype-phenotype correlations for Turner syndrome have not been established, although a lower level of 45,X is generally thought to be associated with a milder phenotype. This limits personalized counseling for women with 45,X/46,XX mosaicism. To better understand the phenotypic spectrum associated with various levels of 45,X/46,XX mosaicism, we compared patients evaluated in the Massachusetts General Hospital Turner Syndrome Clinic to determine if cardiac, renal, and thyroid abnormalities correlated with the percentage of 45,X cells present in a peripheral blood karyotype. of the 118 patients included in the study, 78 (66%) patients had non-mosaic 45,X and 40 (34%) patients had varying levels of 45,X/46,XX mosaicism. Patients with ≤70% 45,X compared with those with >70% 45,X had a significantly lower frequency of cardiac and renal anomalies. The presence of hypothyroidism was somewhat lower for the ≤70% 45,X group, but was not statistically significant. Supplemental tissue testing on another tissue type, typically buccal mucosa, was often useful in counseling patients with 45,X mosaicism. Given the modest sample size of patients with varying levels of mosaicism and the variability of Turner syndrome abnormalities, we hope this preliminary study will inspire a multicenter collaboration, which may lead to modification of clinical guidelines. Because several patients with ≤70% 45,X were ascertained from perinatal care referrals, we still advise women with 45,X mosaicism pursuing pregnancy to receive standard Turner syndrome cardiac surveillance. There is an opportunity to personalize counseling and surveillance for patients based on percentage of 45,X cells on chromosome analysis.

Indexed as

MosaicismPhenotype46, XX Disorders of Sex DevelopmentCells, CulturedFemaleGenetic TestingHumansKaryotypingPrecision MedicineTurner SyndromeCongenital heart defectsCounseling techniquesGenetic counselingKaryotypeRisk managementSex chromosome aneuploidy

Identifiers

PMID33524610
PMCPMC11134314
OpenAlexW3127757268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.